Domain Surgical, a developer of thermal surgical technology, has closed a $35 million Series C financing round led by OrbiMed Advisors, with participation from BioStar Ventures and others. Domain has commercialized a surgical platform for precise cutting and coagulation of soft tissue. Its technology produces surface-only tissue effects without passing electrical energy through the patient and is designed to provide safety and predictability in critical surgical applications.
Founded in 2009, Domain has now raised nearly $47 million in total funding. Previous rounds include a $4.6 million Series A in 2011 (at a $12 million valuation) and a $4.2 million Series B ($52 million valuation). The new investment will be used to evolve Domain's ferromagnetic surgical product platform, produce additional outcomes evidence and expand global sales and distribution.